CY1126031T1 - Συνθεσεις για καθαρισμο του παχεος εντερου και την αντιμετωπιση γαστρεντερικων διαταραχων - Google Patents

Συνθεσεις για καθαρισμο του παχεος εντερου και την αντιμετωπιση γαστρεντερικων διαταραχων

Info

Publication number
CY1126031T1
CY1126031T1 CY20231100253T CY231100253T CY1126031T1 CY 1126031 T1 CY1126031 T1 CY 1126031T1 CY 20231100253 T CY20231100253 T CY 20231100253T CY 231100253 T CY231100253 T CY 231100253T CY 1126031 T1 CY1126031 T1 CY 1126031T1
Authority
CY
Cyprus
Prior art keywords
compositions
gastrointestinal disorders
cleansing
colon
treatment
Prior art date
Application number
CY20231100253T
Other languages
Greek (el)
English (en)
Inventor
Mark G. Currie
Robert SOLINGA
Christopher Leitheiser
Original Assignee
Ironwood Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals, Inc. filed Critical Ironwood Pharmaceuticals, Inc.
Publication of CY1126031T1 publication Critical patent/CY1126031T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY20231100253T 2015-05-01 2023-05-26 Συνθεσεις για καθαρισμο του παχεος εντερου και την αντιμετωπιση γαστρεντερικων διαταραχων CY1126031T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562156077P 2015-05-01 2015-05-01
PCT/US2016/030061 WO2016178979A1 (en) 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders

Publications (1)

Publication Number Publication Date
CY1126031T1 true CY1126031T1 (el) 2023-11-15

Family

ID=55953439

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20231100253T CY1126031T1 (el) 2015-05-01 2023-05-26 Συνθεσεις για καθαρισμο του παχεος εντερου και την αντιμετωπιση γαστρεντερικων διαταραχων

Country Status (23)

Country Link
US (2) US10618938B2 (https=)
EP (2) EP4218789A3 (https=)
JP (5) JP6930919B2 (https=)
KR (2) KR102783759B1 (https=)
CN (2) CN108040482B (https=)
CA (2) CA3172777A1 (https=)
CY (1) CY1126031T1 (https=)
DK (1) DK3288578T5 (https=)
EA (1) EA201792401A1 (https=)
ES (1) ES2947591T3 (https=)
FI (1) FI3288578T3 (https=)
HR (1) HRP20230381T1 (https=)
HU (1) HUE061954T2 (https=)
LT (1) LT3288578T (https=)
MA (1) MA41985B1 (https=)
MD (1) MD3288578T2 (https=)
MX (2) MX2017013928A (https=)
PL (1) PL3288578T3 (https=)
PT (1) PT3288578T (https=)
RS (1) RS64160B1 (https=)
SI (1) SI3288578T1 (https=)
SM (1) SMT202300114T1 (https=)
WO (1) WO2016178979A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3288578T2 (ro) * 2015-05-01 2023-08-31 Ironwood Pharmaceuticals Inc Compoziții pentru curățarea colonului și tratamentul tulburărilor gastrointestinale
US11021514B2 (en) 2016-06-01 2021-06-01 Athira Pharma, Inc. Compounds
MX2024006317A (es) * 2021-11-24 2024-06-19 Ironwood Pharmaceuticals Inc Proceso sintetico para la produccion de agonistas del receptor de guanilato ciclasa c (gcc) modificados.
JP2024541769A (ja) * 2021-11-24 2024-11-12 アイアンウッド ファーマシューティカルズ, インコーポレイテッド 修飾gcc受容体アゴニストの産生のための合成プロセス
IL313184A (en) 2021-11-29 2024-07-01 Ironwood Pharmaceuticals Inc Pharmaceutical compositions for the treatment of visceral pain
WO2026050206A1 (en) * 2024-08-27 2026-03-05 Ironwood Pharmaceuticals, Inc. Combinations of glp-1 and guanylate cyclase c (gc-c) receptor agonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
EP1911763B1 (en) * 2003-01-28 2010-08-11 Ironwood Pharmaceuticals, Inc. Compositions for the treatment of gastrointestinal disorders
US7494979B2 (en) * 2003-06-13 2009-02-24 Ironwood Pharmaceuticals, Inc. Method for treating congestive heart failure and other disorders
WO2007022531A2 (en) * 2005-08-19 2007-02-22 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20110172126A1 (en) * 2008-09-03 2011-07-14 Xenome Ltd Libraries of peptide conjugates and methods for making them
UA108636C2 (xx) * 2010-02-17 2015-05-25 Пептид
DK2681236T3 (en) * 2011-03-01 2018-04-16 Synergy Pharmaceuticals Inc PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
WO2016015055A1 (en) 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Colon cleansing compositions
MD3288578T2 (ro) * 2015-05-01 2023-08-31 Ironwood Pharmaceuticals Inc Compoziții pentru curățarea colonului și tratamentul tulburărilor gastrointestinale

Also Published As

Publication number Publication date
MA41985A (fr) 2018-03-07
MX2017013928A (es) 2018-01-15
EA201792401A1 (ru) 2018-05-31
PL3288578T3 (pl) 2023-08-14
ES2947591T3 (es) 2023-08-11
LT3288578T (lt) 2023-04-25
CA2984437A1 (en) 2016-11-10
JP2020203954A (ja) 2020-12-24
MD3288578T2 (ro) 2023-08-31
US10618938B2 (en) 2020-04-14
BR112017023539A2 (pt) 2018-08-14
SI3288578T1 (sl) 2023-07-31
JP2025169325A (ja) 2025-11-12
WO2016178979A1 (en) 2016-11-10
JP2018519254A (ja) 2018-07-19
JP2022121734A (ja) 2022-08-19
CN108040482A (zh) 2018-05-15
EP3288578A1 (en) 2018-03-07
MX2022013283A (es) 2022-12-13
EP3288578B1 (en) 2023-03-15
CN108040482B (zh) 2022-03-29
CA2984437C (en) 2025-11-18
JP2024015335A (ja) 2024-02-01
KR20250042844A (ko) 2025-03-27
MA41985B1 (fr) 2023-04-28
EP4218789A3 (en) 2023-09-27
US20180148476A1 (en) 2018-05-31
DK3288578T5 (da) 2024-10-07
HUE061954T2 (hu) 2023-09-28
DK3288578T3 (da) 2023-05-01
FI3288578T3 (fi) 2023-05-03
RS64160B1 (sr) 2023-05-31
CA3172777A1 (en) 2016-11-10
KR102783759B1 (ko) 2025-03-21
HRP20230381T1 (hr) 2023-07-07
KR20180005675A (ko) 2018-01-16
US20240199697A1 (en) 2024-06-20
EP3288578B8 (en) 2023-03-29
SMT202300114T1 (it) 2023-05-12
EP4218789A2 (en) 2023-08-02
CN114716514A (zh) 2022-07-08
JP6930919B2 (ja) 2021-09-01
PT3288578T (pt) 2023-03-28

Similar Documents

Publication Publication Date Title
CY1126031T1 (el) Συνθεσεις για καθαρισμο του παχεος εντερου και την αντιμετωπιση γαστρεντερικων διαταραχων
CY1123746T1 (el) Ανθρωποποιημενα tau αντισωματα σε νοσο του alzheimer
CY1124959T1 (el) Αναστολεις λυσινης ειδικης απομεθυλασης-1
CY1124568T1 (el) Φαρμακευτικες συνθεσεις για την αγωγη παθησεων μεσολαβουμενων απο ρυθμιστη διαμεμβρανικης αγωγιμοτητας κυστικης ινωσης
CY1124918T1 (el) Ρυθμιστες ccr2
CY1124407T1 (el) Ενωσεις αναστολεα αυτοταξινης
CY1125245T1 (el) Ετεροκυκλικες ενωσεις ως αναστολεις ρι3κ-γαμμα
CY1124055T1 (el) Ετεροκυκλικες ενωσεις ως ανοσοδιαμορφωτες
CY1122966T1 (el) 5-βρωμο-2,6-δι-(1η-πυραζολ-1-υλ)πυριμιδιν-4-αμινη για χρηση στη θεραπευτικη αγωγη καρκινου
CY1124729T1 (el) Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου
CY1125150T1 (el) Ενωσεις φαινυλο-2-υδροξυ-ακετυλαμινο-2-μεθυλο-φαινυλιου
CY1125127T1 (el) Αναστολεις λυσινης ειδικης απομεθυλασης-1
CY1121550T1 (el) Ενωσεις πυριδινης πλαδιενολιδης και μεθοδοι χρησης
CY1123581T1 (el) Νεες μεθοδοι για την παραγωγη ολιγονουκλεοτιδιων
CY1120729T1 (el) Πεπτιδια και συνθεσεις για τη θεραπεια τραυματισμου των αρθρωσεων
CY1121360T1 (el) Αναστολεις dna-pk
CY1120361T1 (el) Αναστολεις 2,3-διοξυγενασης ινδολαμινης (ido)
EA201890325A1 (ru) Пептидные ингибиторы рецептора интерлейкина-23 и их применение для лечения воспалительных заболеваний
CY1118695T1 (el) Αναστολεις απομεθυλασων ιστονων
EA201290322A1 (ru) Лечение желудочно-кишечных расстройств
CY1122818T1 (el) Παραγωγα 3-((ετερο-)αρυλ)-αλκυλ-8-αμινο-2-οξο-1,3-διαζα- σπε1ρο-[4.5]-δεκανιου
CY1121480T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν δοτες νιτροξυλιου
EA201692091A1 (ru) Хиноксалиновые соединения и их применение
EA201991196A1 (ru) Претерпевшие самосборку диблок-сополимеры, состоящие из pegmema и несущих лекарственное средство полимерных сегментов
CY1122923T1 (el) Παραγωγα 3-((ετερο-)αρυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου